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Abstract
Erythropoietin (EPO) has been recognized as a neuroprotective agent. In animal models of neonatal brain injury, exogenous
EPO has been shown to reduce lesion size, improve structure and function. Experimental studies have focused on short
course treatment after injury. Timing, dose and length of treatment in preterm brain damage remain to be defined. We have
evaluated the effects of high dose and long-term EPO treatment in hypoxic-ischemic (HI) injury in 3 days old (P3) rat pups
using histopathology, magnetic resonance imaging (MRI) and spectroscopy (MRS) as well as functional assessment with
somatosensory-evoked potentials (SEP). After HI, rat pups were assessed by MRI for initial damage and were randomized to
receive EPO or vehicle. At the end of treatment period (P25) the size of resulting cortical damage and white matter (WM)
microstructure integrity were assessed by MRI and cortical metabolism by MRS. Whisker elicited SEP were recorded to
evaluate somatosensory function. Brains were collected for neuropathological assessment. The EPO treated animals did not
show significant decrease of the HI induced cortical loss at P25. WM microstructure measured by diffusion tensor imaging
was improved and SEP response in the injured cortex was recovered in the EPO treated animals compared to vehicle treated
animals. In addition, the metabolic profile was less altered in the EPO group. Long-term treatment with high dose EPO after
HI injury in the very immature rat brain induced recovery of WM microstructure and connectivity as well as somatosensory
cortical function despite no effects on volume of cortical damage. This indicates that long-term high-dose EPO induces
recovery of structural and functional connectivity despite persisting gross anatomical cortical alteration resulting from HI.
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Introduction
Neonatal hypoxic-ischemic (HI) brain injuries involve both
primary destructive events including neuronal death, gliotic
reaction and also secondary maturational disturbances leading to
subsequent abnormal development of cerebral white and gray
matter [1,2]. These damages lead to altered function that range
from severe neurological handicap to behavioral, learning and
attention deficits [2]. The postnatal day 3 (P3) rat shares some
similarities in terms of cortical neuronal, glial and oligodendroglial
development to the very preterm infant (24–28 weeks) [3]. P3-HI
injury damages specific brain regions and is characterized by
diffuse intracortical white matter loss, zones of patchy neuronal
degeneration, altered oligodendrocyte progenitors maturation and
subsequent myelination, and hypertrophic astrocytes with forma-
tion of gliotic scares [4–7]. These neuropathological features are
mainly found in the somatosensory cortex. In direct correlation
with the neonatal HI damage of the deep infragranular cortical
area, including the subplate neurons area, P3-HI injured rats show
profound functional alteration of neuronal response with a
reduced somatosensory amplitude response to whisker stimulus
contralateral to the lesioned hemisphere. However, in the first 3
weeks after birth, partial recovery processes take place in the
establishment of the sensorimotor cortical networks during the
cortical functional maturation period [8].
Erythropoietin (EPO) is a 30.5-kDa cytokine functioning mainly
as a survival and differentiation regulator during erythropoiesis
[9]. In the central nervous system, neurons, glial cells and cerebral
endothelial cells produce EPO and express EPO-receptors (EPO-
R) [9]. EPO has been shown to act as an anti-apoptotic, anti-
inflammatory and neurotrophic mediator both in-vitro and in-vivo
[9,10]. Several studies documented an autocrine production of
EPO not only by astrocytes but also by neurons during conditions
of suffering of the cerebral tissue [11,12]. Hypoxic stress increases
the production of EPO by the neuronal cells in culture [13].
Further, EPO treatment of neurons in culture reverted glutamate-
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induced cell death [14]. In p7 rats, infarct size as a result from
neonatal stroke induced by middle cerebral artery occlusion was
reduced by EPO administration [15]. In neonatal mice and rats
EPO pre-treatment or early after HI insult was also neuroprotec-
tive when assessed early at 2–7 days after insult [16–18]. Finally,
the neuroprotective effect of EPO treatment after neonatal HI was
reported to include a preservation of tyrosine hydroxylase-positive
fibers in the ventral tegmental area and substantia nigra pars
compacta [19]. EPO has also shown anti-apoptotic effects on
oligodendrocytes and promoted neurogenesis and angiogenesis,
which are essential for normal neurodevelopment but also injury
repair [20,21]. Reducing the initial injury and supporting the
subsequent development through neurotrophic factors appear
both important mechanisms in neonatal brain injury [22,23].
Magnetic Resonance Imaging (MRI) and Spectroscopy (MRS)
are non-invasive MR techniques widely used to assess brain
structure and brain metabolism, respectively. Anatomic T2-
Weighted MR images lead to accurate quantification of brain
region volumes and has been used to assess lesion volume early
after HI as well as long term cortical loss [24]. Diffusion tensor
imaging (DTI) is a powerful tool to probe cerebral white matter
through a 3D description of water diffusion in the tissue [25].
Changes in diffusivity values (mean: MD, parallel: D// and
orthogonal: DH) and/or fractional anisotropy (FA) derived from
DTI reveal loss of brain microstructure integrity [26,27]. 1H
magnetic resonance spectroscopy (1H-MRS) has been used to
follow the changes in ‘‘neurochemical profile’’ of the brain during
cerebral development [28]. This technique allows assessment of
several metabolite concentrations (named as the ‘‘neurochemical
profile’’) known to be altered following HI in the P3 pup rat [24].
Recently, a minimally invasive epicranial approach for multielec-
trode recordings of vibrissal somatosensory-evoked potentials
(SEPs) applied to the P3 neonatal HI model revealed long-term
functional deficit [8] and EPO treatment showed sensorimotor
recovery after HI injury in the neonatal mice and in spinal cord
injury [29,30].
EPO has been shown efficient in different models of term and
moderately preterm brain injury [31,32] but has not been used in
a very immature P3 HI model. Further, only short-term protective
treatment regimens have been evaluated. In the present study, we
investigated the neuroprotective effects, including damage reduc-
tion and neurotrophic action, of long-term high dose EPO
administration in the P3-HI model using a multi-modal strategy
that combine histological, macro-structural (MRI), micro-struc-
tural (DTI), neurochemical (MRS) as well as functional (SEP)
assessments.
Materials and Methods
All animal experiments were approved by the Swiss Veterinary
Office and in adequacy with Swiss animal welfare laws. The
unilateral P3 moderate HI model has been described previously
[6,7]. Briefly, P3 male Wistar pups underwent right carotid artery
cauterization under isoflurane anesthesia then after 30 minutes
recovery rat pups were exposed to 6% O2 hypoxia for 30 minutes
under thermoneutral conditions.
Magnetic Resonance Imaging: T2-Weighted Images
All in-vivo MR experiments were performed on an actively-
shielded 9.4T/31 cm magnet (Magnex Scientific, Abington, UK;
Varian, Palo Alto, CA, USA) equipped with 12-cm gradient coils
Figure 1. Myelination and neurofilaments in the ipsilateral cortex. A) Total length of myelinated fibers (mm) of MBP positive stained fibers in
the cortex of Control, NaCl and EPO treated rats. B) MBP average fluorescence intensity in the cortex of Control, NaCl and EPO treated rats. C) Total
length of neurofilaments (mm) of SMI31 stained fibers in the cortex of Control, NaCl and EPO treated rats. D) SMI31 average fluorescence intensity in
the cortex of Control, NaCl and EPO treated rats. All the data are presented as mean 6 SD, *: P,0.05, NaCl vs. Control and EPO vs. Control, n = 12 rats
for each group, NaCl, EPO and Control.
doi:10.1371/journal.pone.0095643.g001
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(400 mT/m, 120 ms) with a quadrature transceive 17-mm surface
RF coil. During measurements, each pup was placed supine within
an adapted holder and continuously anesthetized under a flow of
1.5–2% isoflurane in oxygen. Body temperature was maintained at
37uC using thermoregulated water circulation. 5 h following HI,
T2W Fast Spin Echo (FSE) images with TE/TR = 80/6000 ms;
FOV = 25625 mm and matrix size = 2566128 were used to
detect presence of injury as well as determinate the initial lesion
volume. Only the pups showing hyper-intense signal in the
ipsilateral hemisphere on these acute T2W images were random-
ized for the therapeutic intervention.
EPO Treatment
Animals showing injury on initial MRI were selected and
randomized to NaCl group, injected intraperitoneally with NaCl
0.9% or to EPO group, injected intraperitoneally with recombi-
nant human EPO (rhEPO, Roche, Basel, Switzerland) 10 U/g
body weight/day during the first week after HI (P3 to P10) and
then 5 U/g body weight 36/week until P25. A Control group,
which was not subjected to surgery and injection, was also studied.
1H Magnetic Resonance Spectroscopy
To study the effects of the treatment on brain metabolic profile,
22 days following HI (P25), 1H-MRS was performed. At P25, FSE
images using the same parameters as at P3 were performed for
positioning of 1H-MRS voxel of interest (1.561.562.5 mm3).
Spectra acquisition was performed as previously described [24]
using an ultra-short echo time (TE/TR = 2.7/4000 ms) SPECIAL
spectroscopy method [33]. Measurements were made in the area
of somatosensory cortex as reported previously [5–7,24] as well as
the corresponding cortical area for the Control group (n = 8 rats
for each group, NaCl, EPO and Control). 70 series of FIDs (12
averages each) were acquired, individually corrected for frequency
drift, summed together and corrected for residual eddy current
effects using the reference water signal. Proton spectra were
analyzed with LCModel [34] as previously described [24].
Metabolites were quantified resulting in a neurochemical profile
of the cortical lesion for the EPO and NaCl groups and of the
cortex in the Control group.
Volumetric Measurements
From FSE images, volumetric measurements were performed
using Anatomist/Brain Visa [35]. At P3, lesion volume (LV) as
well as ipsilateral cortical volume (ICV) was measured; at P25
contralateral cortical volume (CCV) as well as ipsilateral cortical
volume (ICV) was quantified. Volumetric measurements resulted
in percentage of injured cortex ( = (LV/ICV)6100) at P3 and
percentage of cortical loss ( = [(CCV-ICV)/CCV]6100) at P25
(n = 8 rats for each group, NaCl and EPO).
Somatosensory-evoked Potentials (SEPs) Recordings
Following 1H-MRS, epicranial recordings of somatosensory
evoked potentials (SEP) were carried out at P27–P28 under
isoflurane anesthesia as previously described [8] (n = 11, 10 and 9
rats for NaCl, EPO and Control group, respectively). Before
surgery, anesthesia was induced with 3–4% isoflurane then rats
were mounted in a stereotaxic frame. Isoflurane was lowered at
2.5% and local bipuvacaine anesthesia was applied to the scalp.
The skull was exposed by retracting the skin from the frontal to the
occipital bones. A 16 steel electrodes grid dipped in EEG paste
(500 mm in diameter, final impedance < 50 kOhms) was applied
on the skull, covering the entire exposed surface (see [8] for
electrode coordinates). SEP were recorded at 0.7–1% isoflurane
with a custom-made amplifier (gain 5000X; band pass filters 1–
Figure 2. T2 weighted MRI at P3 and P25. T2 weighted images of
typical EPO and NaCl treated pup rats at 5 h (P3) and 22 d (P25) after
injury showing the evolution of the ischemic lesion in the ipsilateral
cortex (right). At P3, ischemic lesion appears as hypersignal. At P25,
images present a large cortical loss in the ipsilateral cortex and an
abnormal development for the both groups. Remaining trace of lesion
was observed for the both groups at the bottom of the cortex (arrows).
doi:10.1371/journal.pone.0095643.g002
Figure 3. Volumes of cortical injury at P3 and loss at P25. Upper
panel: percentage of cortical loss at P25 as a function of the percentage
of injured cortex at P3 for the both groups: EPO and NaCl. A strong
correlation independent of the group was found: R2 = 0.67; P=0.0001.
Lower panel: percentage of injured cortex (Inj. Cx) at P3 and percentage
of cortical loss (% Cort. loss) at P25 for EPO and NaCl groups. There were
no statistical differences between EPO and NaCl groups in terms of
cortical injury at P3 and loss at P25. Data are presented as mean 6 SD,
n = 8 rats for each group, NaCl, EPO and Control.
doi:10.1371/journal.pone.0095643.g003
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500 Hz, analog to digital conversion at 2 KHz [8]). During
recordings, absence of withdrawal hind limb reflex was controlled
and body temperature was maintained at 37uC using a heating
pad.
Unilateral somatosensory stimuli were delivered simultaneously
to all large whiskers on one side of the snout through a solenoid-
based stimulator device [8,36]. Stimuli consisted of 500 mm back-
and-forth deflections with 1 ms rise time. Right-sided and left-
sided series of 50 stimuli were applied with an inter-stimulus
interval of 9 seconds.
Individual SEPs were calculated offline by averaging responses
100 ms prestimulus to 500 ms poststimulus. Maximum positive
voltage peaks were measured for each SEP at right and left S1
electrodes (e4, e12).
Ex-vivo Diffusion Tensor Imaging
Following SEPs, animals received an overdose of intraperitoneal
injection of sodium pentobarbital and were transcardially perfused
with NaCl 0.9% followed by with 4% paraformaldehyde on 0.1%
PBS for tissue fixation. DTI experiments on ex-vivo brain were
performed with a transceiver 25-mm birdcage RF coil (n = 6 rats
for each group, NaCl, EPO and Control). Spin Echo sequence
(TE/TR = 30/5000 ms) was used, diffusion gradients were applied
along dual gradient diffusion gradient sampling scheme [25]
(Gdiff = 22 G/cm, d= 3 ms and D= 20 ms given a b-value of
1184 s.mm22). 20 slices of 0.8 mm thickness with an in-plane pixel
size of 70 mm were acquired in the axial plane. Using a homemade
Matlab (Mathworks, Natick, MA, USA) software [27,37], region of
interest (ROI) were manually delineated on four different regions
of the brain: the external capsule (EC), the internal capsule (IC),
the corpus callosum (CC) and the superficial layer of sensorimotor
cortex (Cx) at four different levels of the brain corresponding to the
genu, the body (2 different parts of the body) and the splenium of
the corpus callosum.
Immunohistology
Ex-vivo imaged brains added with non-scanned ones at P25
were used for immunohistological studies (n = 8 rats for each
group, NaCl, EPO and Control). Anti-Glial fibrillary acid protein
(anti-GFAP, Dako, ZO334, Glastrip, Denmark) and anti-Neuro-
nal Nuclei (anti-NeuN, Chemicon, Billerica, MA, USA) staining
were used to observe the long-term effects of EPO on astrocytes
activation, resulting in formation of gliotic scare and on neuronal
death and survival, respectively. Anti-Myelin basic protein
antibody (anti-MBP, Chemicon, Billerica, MA, USA) was used
to determine white matter injury with altered myelination. Anti-
Neurofilament antibody (anti-SMI 31, Chemicon, Billerica, MA,
USA) was used to assess neurofilament integrity.
After brain fixation as previously described, pup brains were
cryoprotected in 30% sucrose and frozen. Contiguous 12 mm
sections at the level of the dorsal hippocampus were cut on a
cryostat and collected on superfrost slides (ThermoScientific,
Waltham, MA, USA). Immunostaining was performed using the
following protocol: sections were washed in a 0.1% PBS and non-
specific binding was blocked by incubating the slides in 0.1% PBS/
5% BSA/0.3% triton/3% normal goat serum (NGS). They were
then incubated overnight at 4uC with the different primary
antibodies: NeuN 1:200 in 0.1 M PBS/pH 7.4/5% BSA/1%
NGS, GFAP 1:400 in 0.1 M PBS/pH 7.4/5% BSA/1% NGS,
MBP 1:200 in 0.1 M PBS/pH 7.4/5% BSA/1% NGS and SMI
31 1:200 in 0.1 M PBS/pH 7.4/5% BSA/1% NGS. This was
followed by 2 hours incubation at room temperature with
secondary goat Alexa 488 anti-rabbit 1/1000 (Lifetechnologies,
Carlsbad, CA, USA) for GFAP and Goat Alexa 555 anti-Mouse
1/1000 (Lifetechnologies, Carlsbad, CA, USA) for NeuN, MBP
and SMI 31 in 0.1 M PBS/pH 7.4/5% BSA/1% NGS. Slides
were finally washed and cover slipped with mounting media.
For each specific staining and each brain, three slides of 220 mm
sections apart were scanned using the Mirax (Zeiss, Go¨ttingen,
Germany) and analyzed. GFAP-positive staining was evaluated in
the ipsilateral cortex of HI animals. A scoring system with scores
ranging from 0 (no gliotic scare) to 4 (strong staining covering the
whole surface of parietal cortex in the deeper layers) was used.
Other immunostaining were evaluated in Metamorph (Molec-
ular Devices, Sunnyvale, CA, USA) using specific automated
journals defined for desired unbiased quantification. The quanti-
fication of neurons was done by counting DAPI and NeuN positive
cells in both cortices of each animal for the three groups leading to
number of neurons in the ipsilateral and contralateral cortices for
each group (NnI and NnC, respectively). The percentage of
neuronal loss in the ipsilateral cortex was then calculated using the
formula: ((NnC–NnI)/(NnC+NnI))6100, for each group.
The same automated journal was used to quantify length of
myelinated fibers (from MBP staining) and neurite outgrowth
(from SMI 31 staining). Briefly, first the skeletons of the fibers were
detected and measured and, second the distance from the cortex
surface to the extremity of the fibers was measured. Finally, the
second distance was subtracted to the first one, resulting in a fiber
length taking into account the cortical thickness. Resulted lengths
were all summed together leading to total length of myelinated
fibers and total length of neurofilaments in the ipsilateral cortex for
each rat of the three groups.
The average fluorescence intensity for MBP and SMI 31
positive staining deducted from the background was assessed in the
entire surface of ipsilateral cortices within each animal of the three
groups. In the genu of the corpus callosum, in the internal and
external capsule, three ROI having the same surface were drawn
in each zone and immunofluorescence was measured. The
background was subtracted and the mean of the three zones was
calculated, indicating the level of myelination and of intact
neurofilaments in these areas.
Statistical Analysis
All the data are presented as mean 6 standard deviation (SD)
except for SEP results presented as mean 6 standard error of the
mean (SEM). For MRI-MRS and immunohistology, a Wilcoxon
test was used to compare values between ipsilateral and
contralateral sides of the same animal and a Mann-Whitney test
to compare statistically values between the groups (n = 8 for each
group), both using Matlab (Mathworks, Natik, MA, USA). For
SEPs, as voltage peaks and ratio distributions turned out to be
normal, ANOVA and t-tests were applied for between and within
group comparisons. Analyses were performed using Cartool
(http://brainmapping.unige.ch/Cartool.htm) and Matlab (Math-
works, Natik, MA, USA).
Results
At the end of the treatment period, hemoglobin and hematocite
were measured in both NaCl and EPO treated animals and no
difference was seen.
Astroglial Scar Formation
GFAP-positive staining was present in the ipsilateral cortex of
HI animals. Various degrees of astrogliosis in layers IV, V, VI in
the parietal cortex of the right injured hemisphere were observed.
In the NaCl group, 28.55% of animals showed a score of 0,
14.25% a score of 1, 28.55% a score of 2 and 28.55% a score of 3.
Long-Term Erythropoietin after HI Injury
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In the EPO group, 42.85% showed a score of 0, 14.25% a score of
1, 28.55% a score of 3 and 14.25% a score of 4. No significant
score difference was found between NaCl and EPO groups.
Neuronal Loss Assessment
Quantification of neurons revealed a significant increase of
neuronal loss in NaCl compared to Control groups (19.1613.9%
vs. 0.961.4%, respectively; P#0.0001) as well as between EPO
and Control groups (30.9% 625.1 vs. 0.9% 61.4 P#0.0001). No
significant difference was observed between EPO and NaCl
groups.
Myelin Staining
In the cortex, myelinisation along the fibers measured as the
total cortical MBP positive fibers (figure 1A) was reduced in NaCl
compared to Control groups (376768 mm 6102627 and
559701 mm 643771, respectively; P= 0.007) while there was no
significant difference neither between EPO and Control groups
(3319536247332 mm and 559701643771 mm, respectively) nor
between NaCl and EPO groups.
The average fluorescent intensity of MBP staining (figure 1B)
was significantly reduced in the EPO compared to Control
(12.9867.85 and 21.2564.43, respectively; P= 0.014) as well as in
the NaCl compared to Control groups (17.1368.5 and
21.2564.43, respectively; P= 0.011). EPO group vs. NaCl group
presented no significant difference. In the corpus callosum, in the
external and internal capsules, the quantifications of the MBP
fluorescent signal did not reveal any significant difference between
the groups Control, NaCl and EPO (data not shown).
Neurofilaments
In the cortex, the analysis of neurofilaments length (figure 1C)
did not reveal any significant difference between NaCl, EPO and
Control groups (3249706140475 mm, 3902356220066 mm and
422241682999 mm, respectively). In the other hand, the average
fluorescent intensity of SMI 31 staining (figure 1D) was
significantly reduced in the EPO compared to Control groups
(9.3262.51 vs. 15.2964.66, respectively; P= 0.04) as well as
between the NaCl and Control groups (9.6966.38 vs. 15.2964.66,
respectively; P= 0.02). There was no significant difference between
NaCl and EPO groups. No significant difference was observed in
the corpus callosum, external and internal capsules, in SMI 31
quantifications between the three groups (data not shown).
Cortical Volumes
Figure 2 shows multi-slice T2-weighted FSE brain images of a
typical EPO and NaCl treated pup rat at different time points (5 h
(P3) and 22 d (P25) after injury) showing the evolution of the
ischemic lesion in the ipsilateral cortex for the both groups. At P3,
ischemic lesion appears in hypersignal due to the presence of
edema (figure 2). At P25 for the both groups, a small residual T2
hypersignal was observed (figure 2, arrows) at the level of the
rhinal fissure. No cyst was present but images showed cortical loss
in the ipsilateral hemisphere in both groups. There was no
difference in the percentage of injured cortex at P3 before
treatment randomization between EPO and NaCl groups
(38.8616.4% vs. 41.469.9% for EPO and NaCl, respectively)
showing the homogeneity of injury in both groups. A strong
correlation independent of the groups was found between the
percentage of injured cortex at P3 and the percentage of cortical
loss at P25 (figure 3, R2 = 0.67; P= 0.0001). At P25, the
percentage of cortical loss was not different between EPO and
NaCl treated pups (40.4619.5% vs. 41.767.8% for EPO and
NaCl, respectively).
Metabolic Profile of Cortex
Good spectral quality was achieved in the current study, as
judged from water linewidth, obtained with FASTMAP, ranging
from 8 Hz to 12 Hz. Due to very thin cortical structure in the rat
pup brain, MRS was performed on a very small volume of 12 ml
placed on the cortex (figure 4). On the overall study signal to noise
ratio was equal in average to 1563. These consistent data were
subjected to spectral analysis and absolute quantification using an
LCModel. It should be noticed that the voxel of interest was
always placed higher than the remaining T2 hypersignal previously
described, avoiding a possible water contamination in the
metabolite quantifications.
Table 1 summarizes the changes observed on metabolite
concentrations. Comparing ipsilateral and control cortices, for
both the NaCl group and the EPO group significant decrease of
[Glu] as well as [totalNAA], [Glu]+[Gln] and [totalCr] was
observed in the lesion area. In addition in NaCl group, [NAA],
[Cr] and [PCr] were also significantly decreased in the injured
cortex. Ipsilateral cortical ‘‘neurochemical profiles’’ of EPO versus
NaCl did not show any significant difference.
Somatosensory Evoked Potentials
To analyze the effect of the EPO treatment on functional
recovery, we recorded SEP in response to whisker stimulation
(figure 5A). As already described in previous studies [8], the
earliest and strongest SEP component in response to unilateral
whisker stimulation shows the activation of the contralateral S1
region in control and in HI groups (figure 5B). The topographic
voltage maps at the peak amplitude of this SEP component suggest
a deficit in the amplitude of the response to left-sided whisker
stimuli in the right S1 cortices of the NaCl as compared to the
control and EPO groups as well as to the response to right-sided
whisker stimuli in their left, non-injured, hemisphere. No
significant difference was found in the mean voltage peak
amplitudes recorded above S1 in the non-injured hemisphere
between the 3 groups (Mean 6 SEM: control: 461684 mV;
NaCl = 507694 mV; EPO = 388683 mV; P= 0.65, one-way AN-
Figure 4. Metabolic profile of cortex. Typical in vivo localized 1H-
NMR spectra at 9.4T in the ipsilateral cortex of one NaCl treated rat pup
(right) as well as in the same area of a Control rat cortex with respective
metabolite assignments. All spectra (SPECIAL, TE/TR= 2.8/4000 ms,
NT = 840) were displayed with Gaussian apodization (gf = 0.11 s) and
scaled relative to the concentration of macromolecules. Abbreviations:
Mac, macromolecules; Asc, ascorbate; Asp, aspartate; GPC, Glycero-
phosphocholine; PCho, phosphorylcholine; Cr, creatine; PCr, phospho-
creatine; GABA, c-aminobuttyric acid; Glc, glucose; Glu, glutamate; Gln,
glutamine, Ins, myo-inositol; Lac, lactate; NAA, N-acetylaspartate; NAAG,
N-acetylaspartylglutamate; PE, phosphoethanolamine and Tau, taurine.
doi:10.1371/journal.pone.0095643.g004
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OVA; figure 5C). However the SEP peak amplitude is greatly
reduced in the right injured hemisphere of the NaCl group
compared to the control group with the EPO group showing an
intermediate SEP peak amplitude reduction (Mean 6 SEM:
control: 463673 mV; NaCl = 291658 mV; EPO = 359653 mV).
ANOVA analyses failed to show a group effect because of the
variability of the SEP voltage values between individuals.
However, within group comparisons using paired statistics
revealed in the animals of the NaCl group a strong and significant
reduction of contralateral SEP amplitude in the right hemisphere
as compared to contralateral SEP in their left hemisphere
(P= 0.02, paired t-test, two tailed). No difference was found
between contralateral SEPs both in the control and in the EPO
groups. Accordingly, the mean SEP ratios between right and left
peak amplitudes was significantly different between groups
(P= 0.04; ANOVA): while the right/left ratio is around 100% in
the control and the EPO groups, a strong bias is observed in the
NaCl group, with a mean value in the injured hemisphere
reaching only 6269% of the contralateral side (Figure 5D). Such a
bias indicates reduced amplitude of the response in the injured
hemisphere however a mechanism of compensation in the
contralateral non-injured hemisphere may also participate to the
bias of the SEP in the NaCl group following the unilateral lesion.
Microstructure Evaluation by DTI
Direction encoded brain color maps of a typical EPO and NaCl
treated pup rats are presented on figure 6. The excellent SNR and
resolution (70 mm in-plane) of these images allowed an accurate
estimation of diffusion tensor derived parameters. No obvious
visual differences appeared between the two maps. Abnormal
development was obvious for both rats with a dissymmetry
between ipsilateral and contralateral hemispheres (i.e. thinner
cortex in the injured hemisphere due to cortical loss following
injury). The contralateral hemisphere was comparable to the one
of the control group (not shown). It should be noticed that these
diffusion data were acquired on ex-vivo fixed brain, thus the
diffusivity values are significantly lower than in-vivo acquisition
whereas FA values remained unchanged after fixation as
previously described [38].
FA measurements were made at four different levels of the brain
on axial slice corresponding to the levels of the genu, the body (2
image-planes) and the splenium of the corpus callosum. ROIs are
overlaid on direction encoded color maps on figure 6. Results are
presented as mean values over the four different levels (Figure 7).
In the IC, EC and CC, FA values were found significantly lower in
the NaCl group compared with Control group whereas there was
no significant difference between EPO and controls. Only in the
CC, a significant difference in FA values was observed between
EPO and NaCl. In the EC, FA = 0.5160.02, 0.4460.05,
0.4960.03 for Control, NaCl and EPO, respectively; in the IC,
FA = 0.4960.04, 0.4160.05, 0.4560.04 for Control, NaCl and
EPO, respectively and in the CC, FA = 0.6560.04, 0.4960.05,
0.5960.04 for Control, NaCl and EPO, respectively. This FA
decrease was related to a significant increase of the radial
diffusivity. In the EC, DH= 2.0760.17610
24 mm2.s21,
2.5460.1761024 mm2.s21, 2.4260.4661024 mm2.s21 for Con-
trol, NaCl and EPO, respectively; in the IC,
DH= 2.2160.19610
24 mm2.s21, 2.5860.2761024 mm2.s21,
2.4760.4261024 mm2.s21 for Control, NaCl and EPO, respec-
tively and in the CC, DH= 1.5860.17610
24 mm2.s21,
2.4160.2661024 mm2.s21, 2.2660.5061024 mm2.s21 for Con-
trol, NaCl and EPO, respectively. In the cortex, no significant
difference was found between the groups (NaCl, EPO and
Control) neither on diffusivity values, nor on FA (Figure 7).
Discussion
Using different approaches we aimed at evaluating the
protective role of long-term high dose of EPO treatment after
moderate HI injury in the immature P3 rat brain. In this study,
Table 1. Neurochemical profiles.
EPO vs. CTL NACL vs. CTL CTL
Mac 1.860.1 1.860.1 1.960.2
Cr 3.160.5 3.060.5 *Q 3.660.5
PCr 4.562.2 3.560.6 **Q 4.260.5
Glc 4.263.2 2.960.8 3.763.1
Gln 2.660.6 2.960.4 *Q 3.361.0
Glu 7.160.9 **Q 6.961.6 *Q 9.361.3
NAA 7.661.4 7.260.9 **Q 9.060.8
Tau 6.561.2 6.261.7 7.560.6
NAA+NAAG 8.361.3 *Q 8.060.9 **Q 9.961.0
Glu+Gln 9.661.0 ***Q 9.861.8 *Q 12.661.8
GPC+PCho 0.560.2 0.660.2 0.660.2
Cr+PCr 7.361.7 *Q 6.560.9 **Q 7.960.8
PCr/Cr 1.160.2 1.260.3 1.260.2
Glu/Gln 2.960.9 2.460.5 3.060.9
Metabolite concentrations in the ipsilateral cortex of EPO and NaCl treated rat pups as well as in the control cortex, and summary of observed metabolite changes
following HI in the EPO and NaCl treated rats when compared to the control rats. Changes are displayed with specific orientated arrows: ‘‘q’’, increase and ‘‘Q’’,
decrease. The number of ‘‘*’’ represents significant level of P,0.05, 0.01, 0.001 respectively. Notice that no significant difference was found between EPO and NaCl
cortices. All concentrations are presented as mean 6 SD in mM/g except the ratios. Abbreviations: Mac, macromolecules; Asc, ascorbate; Asp, aspartate; GPC, Glycero-
phosphocholine; PCho, phosphorylcholine; Cr, creatine; PCr, phosphocreatine; GABA, c-aminobuttyric acid; Glc, glucose; Glu, glutamate; Gln, glutamine, Ins, myo-
inositol; Lac, lactate; NAA, N-acetylaspartate; NAAG, N-acetylaspartylglutamate; PE, phosphoethanolamine and Tau, taurine.
doi:10.1371/journal.pone.0095643.t001
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Figure 5. Functional evaluation with SEP. A. Design of the epicranial recording setup. SEPs were recorded in response to unilateral left-sided or
right-sided whisker stimuli using an array of 16 epicranial electrodes (n = 11, 10 and 9 rats for NaCl, EPO and Control group, respectively). On the right,
an example of the average superimposed SEP traces of all electrodes recorded in one control animal in response to 50 right whisker stimuli. The
dashed line indicates the time of the peak positive response typically recorded at the contralateral S1 electrode and characterizing the first SEP
component. B. Color-coded voltage maps at the time of the peak response of the grand average for right-sided (upper row) and left-sided (lower row)
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long-term EPO treatment HI injury in the P3 rat brain did not
provide gross cortical grey matter protection but showed partial
protective effects on metabolism, white matter structure and
somatosensory function. The neurochemical profile of EPO
treated rats presented less significant changes than the one of
NaCl treated rats. EPO protected the integrity of several white
matter tracts as depicted by normalized DTI derived parameters
values at P25. From a functional point of view, long-term EPO
treatment after P3 HI brain injury promoted whisker stimulated
somatosensory functional recovery at P27–P28 to near normal
levels.
In a previous study we observed that females rat pups showed
smaller injury after HI injury at P3 with better recovery and
reduced cortical damage at P25 compared to males [24]. As a
consequence of this differential level of damage and recovery,
evaluation of EPO effects on HI injury in P3 females would have
been difficult to distinguish from the spontaneous recovery in
absence of treatment. For this reason, in this therapeutic study we
chose to treat and assess male pups only.
There is an important number of published studies of EPO
given prior or after a neonatal insult in mice or rats that showed a
reduction of the damage with decrease of cell death, not only
neurons but also oligodendrocytes with preserved myelination
[31,32]. Furthermore, when administrated acutely after neonatal
ischemia, EPO is not only neuroprotective but also stimulates
angiogenesis and neurogenesis [39]. It is important to notice that
in the majority of these studies, assessment of brain damage was
performed a few days after the insult and after short-term
treatment only. Moreover, most of these neonatal models of injury
did use older pups with a more mature brain at time of injury and
treatment. Further, these models are more severe with mild to
severe brain damage compared to the one used in this study. Our
study investigated a long-term treatment of EPO during 3 weeks
with high dose (10 U/g) of EPO during the first week. This
treatment regimen does not show similar neuroprotection
compared to the shorter therapeutic intervention but it is also
difficult to compare as in these studies EPO effect was assessed
earlier. A previous study reported that an early administration of
EPO over a period of 1 week after HI on P7 rats resulted in
reduced infarct volume, significant enhancement of functional
revascularization and neuronal replacement in the ischemic
hemisphere [15]. In our study, despite early and sustained EPO
administration no reduction of infarct size at P25 was seen with
any increased neuronal survival measured by NAA concentration
and neuronal counts in the EPO group. Moreover, exogenous
EPO did not attenuate astrogliosis as depicted by the 50% of EPO
treated animals showing significant glial scaring not different from
the untreated animals. In the ipsilateral cortices of EPO treated
rats, astrogliosis was present and very strong or completely absent.
This might be dependent on the extent of the primary injury at P3
as a variability of the lesion size is observed at this time point as
depicted by the standard deviation of the percentage of injured
cortex at P3. Indeed the degree or nature of the injury itself in the
acute phase may elicit differential level of therapeutic effect of
EPO. One potential mechanism for these differential actions of
EPO under different degrees of injury may be the regulation of
stimulation in the Control, NaCl and EPO groups. C. Histograms showing for all groups the mean6 SEM voltage amplitude for the peak SEP response
at the S1 electrode (white dots) in the non-injured (right, e12) and injured (left, e4) hemispheres in response to contralateral stimuli. D. Mean 6 SEM
ratios calculated between peak SEP amplitudes at the S1 electrodes.
doi:10.1371/journal.pone.0095643.g005
Figure 6. DTI analysis of microstructure. Direction encoded color maps of typical P25 Control, EPO and NaCl pup rat brain at four different
image-planes corresponding to the four levels of DTI indices measurements: Splenium, Body, Body and Genu of the corpus callosum. The different
ROIs analyzed are overlaid on the Control map: external capsule (EC), internal capsule (IC), corpus callosum (CC) and cortex (Cx).
doi:10.1371/journal.pone.0095643.g006
Long-Term Erythropoietin after HI Injury
PLOS ONE | www.plosone.org 8 April 2014 | Volume 9 | Issue 4 | e95643
EPO-R [40]. In fetal sheep asphyxia model, expression of EPO-R
was increased on astrocytes in brief asphyxia insult but required
repeated asphyxia insults to be increased on neurons [41]. It also
appears that EPO-R expression is different in the core of the injury
compared to the penumbra and is mainly increased on apoptotic
neurons [42]. Therefore, the moderate HI injury at P3 would lead
to a weak increase of EPO receptors on neurons and exogenous
EPO would be in excess compared to EPO-R with limited
therapeutic effect as not bound to its target.
The presence of astrocytes might hamper the recovery of
cortical tissue. High doses of EPO may have an adverse effect as it
has been reported that high EPO dosage promotes the prolifer-
ation of astrocytes [43]. EPO exerts its neurotrophic role but in the
same time activates astrocyte proliferation which accelerates
oligodendrocytes maturation that should promote myelin repair
[43].
Analyses of MBP staining showed no difference between the
EPO and NaCl group neither in the corpus callosum nor in the
internal capsule. Again dosage used might be implicated as high-
dose of EPO (20 U/g) failed to restore myelination and function
after neonatal HI in mice [30]. Nevertheless, in the same regions
FA values were restored in the EPO group. The data obtained by
ex-vivo DTI and SEP recordings showed that EPO has the potential
to enhance white matter reorganization and gray matter
functional recovery after injury. In the EPO group FA values
were restored to values comparable to control in white matter
indicating microstructural recovery whereas the NaCl group
showed lower FA than control indicating WM tract microstructure
disruption. The discrepancy between MBP and microstructural
assessment with FA is not surprising as not only the myelin
influences FA in white matter but also axonal diameter or axonal
compaction [44,45]. For instance, Favrais et al. observed reduced
FA in several brain regions following inflammatory injury
attributed to axonopathy [46]. Axonal evaluation using electronic
microscopy would be necessary to address this question of an effect
of EPO on axonal recovery or/and myelin compaction or axonal
diameter. Importantly, SEP results indicate that EPO treatment
induces functional recovery after HI injury that was not present in
the animal that received NaCl only. Indeed, Iwaı¨ et al. [47]
reported similar results in a neonatal rat model where adminis-
tration of EPO was ineffective at decreasing infarct volume but
significantly improved neurological function outcomes. These
findings suggest that gross preservation of neural tissue is not a
definite requirement for the recovery of neurological function and
that EPO is beneficial for supporting neuronal plasticity and
connectivity establishment. The restoration of neurological func-
tion is influenced by a variety of factors, such as the reorganization
of surviving neuronal tissue, the restoration of myelin and
oligodendrocytic architecture and gross anatomical recovery is
less a prerequisite than improved connectivity. Chan et al. [48]
Figure 7. Microstructure assessment with DTI. Histogram of diffusivities (Mean: MD, axial: D//and radial: DH) as well as fractional anisotropy (FA)
values6 SD measured in the in the external capsule (EC), internal capsule (IC), corpus callosum (CC) and cortex (Cx) of the EPO, NaCl and Control rats
(n = 6 rats for each group, NaCl, EPO and Control, mean values over the four different images planes corresponding to the one of the figure 6; *, `, {:
P,0.05 NaCl vs. Control, EPO vs. Control and EPO vs. NaCl, respectively).
doi:10.1371/journal.pone.0095643.g007
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reported 10 weeks after HI injury induced at P9 on mice and
without neuroprotective therapy an increased FA in several WM
tracts attributed to WM reorganization despite a large loss of grey
matter. EPO could stimulate this WM reorganization as depicted
by the restoration of FA values in different WM tracts despite no
gross anatomical recovery.
Conclusion
In this study we assessed the effects of long-term high dose of
EPO following HI in the P3 pup rat with a multi-modal protocol.
Such a protocol is very powerful to evaluate neuroprotective
effects of EPO with a wide range of information including
functional, macro- and micro-structural, metabolic and histologic
assessment. In conclusion, long-term treatment with EPO in the
P3 rat brain after HI injury showed functional recovery in the
somatosensory cortex, partial white matter microarchitecture
preservation and reduction of metabolic alterations despite
absence of gross neuroprotection with no cortical volume and
neuronal density recovery. This study indicates that further
refinements concerning EPO dose and regimen of administration
are needed to achieve neuroprotection in the preterm brain.
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